Bowman v. Monsanto Co.

Supreme Court Case involving: patents, bioengineering, biotechnology, agriculture industryBackground: Farmers who buy seeds from Monsanto, such as the soybeans containing the Roundup Ready gene which makes plants immune to the herbicide Roundup, must sign an agreement with the company not to save the seeds. This ensures that farmers who want… Read More»

Read More

Mutual Pharmaceutical Co. v. Bartlett

Supreme Court Case involving: pharmaceuticals, FDA regulation, medical industryBackground: In 2004, a New Hampshire woman, Karen Bartlett, took Mutual Pharmaceutical Co.’s generic non-steroidal anti-inflammatory drug, sulindac. Bartlett suffered a known, but rare, skin hypersensitivity reaction. It was extremely severe and ultimately left here severely disfigured as two-thirds of her body was covered in… Read More»

Read More

Kirtsaeng v. John Wiley & Sons, Inc.

Supreme Court Case involving: copyright, importing/exporting, publishing industryBackground: Supap Kirtsaeng came from Thailand to the United States in 1997 to study at Cornell and later at the University of Southern California. While in the United States, Kirtsaeng had friends and family in Thailand buy copies of textbooks, where they were sold at a… Read More»

Read More

Gunn v. Minton

Supreme Court Case involving: patents, licensing, malpracticeBackground: Vernon Minton developed a computer program intended to make securities trading easier, known as TEXCEN, and then leased the system to a securities brokerage in 1995. In 2000, he obtained a patent for his invention and then, represented by Jerry Gunn, he filed a patent-infringement lawsuit… Read More»

Read More

Already, LLC v. Nike, Inc.

Supreme Court Case involving: trademarks, business promisesBackground: In July 2009, Nike, Inc. filed suit against Already, LLC for selling shoes similar to its Air Force 1 shoe, a design with multiple federal trademarks owned by Nike. In November 2009, Already, LLC counterclaimed to cancel Nike’s trademark. In a move to avoid further… Read More»

Read More

Federal Trade Commission v. Actavis

Supreme Court Case involving: patents, antitrust law, pharmaceuticals, generic drugs, FTC, medical industryBackground: Developing new drugs is an expensive and time consuming process that involves years of research and the investment of large sums of money in preclinical and clinical trials. Pharmaceutical companies make much less money as soon as their patents run out and generic… Read More»

Read More

Welcome

Welcome to the Spring Issue of the Innovation E-Review.On April 15th, the New York State Science and Technology Law Center and the New York Academy of Sciences hosted a conference titled: Building Human Capital to Drive New York’s Innovation Economy. Representatives from universities, venture capital funds, government, and industry lead discussions… Read More»

Read More

Resource Spotlights: Upstate Connectivity

The development of professionals with appropriate experiences and skills is certainly crucial to a successful innovation economy. Another equally important aspect is creating and utilizing connections. The conference highlighted the importance of investment resources in building these connections. Two resources striving to establish an economy based on innovation in the… Read More»

Read More